0 items USD 0.00Search
- Did you mean
- immune disease
Your search for "autoimmune disease" gave back 18199 results.
The global Ciclosporin market is projected to reach US$ 32 million in 2029, increasing from US$ 23 million in 2022, with the CAGR of 4.8% during the...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Global Biosimilar Monoclonal Antibodies Market will register a 27.5% CAGR in terms of revenue, the market size will reach USD 9.24 Billion by 2024,...
Catalog:
MRRPB2
April 2019
Price: USD 3,660.00
The global PROTAC Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %...
Catalog:
GIR
March 2024
Price: USD 3,480.00
The global Remicade (Infliximab) Monoclonal Antibody market size is projected to grow from US$ 2494.5 million in 2022 to US$ 3703.9 million in 2029;...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal\'s skin, lacerations of the musculature, mucous membranes...
Catalog:
GIR
January 2023
Price: USD 3,480.00
The global Cyclophosphamide market size was valued at USD 662.1 million in 2023 and is forecast to a readjusted size of USD 761.1 million by 2030...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Biosimilar and Biologics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a...
Catalog:
GIR
March 2024
Price: USD 3,480.00
Methotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Autoimmune Hepatitis is a serious condition that may worsen over time if not treated. Autoimmune Hepatitis can lead to cirrhosis and liver failure...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Highlights The global Biopharmaceutical Contract Manufacturing market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
ZEPOSIA (ozanimod) is a new oral treatment for adults with relapsing forms of MS The global Zeposia market is projected to reach US$ 1239.7 million...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Remicade (Infliximab) Monoclonal Antibody market size is expected to reach $ 3781.3 million by 2029, rising at a market growth of 5.4%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Xatmep is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Rare Disease Clinical Trial market is projected to reach US$ 57 million in 2029, increasing from US$ 45 million in 2022, with the CAGR of...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Monoclonal antibody treatment is a type of targeted therapy that uses specific antibodies to identify and attack cancer cells or other diseased cells...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
